DUO System
Severe Tricuspid Regurgitation
Pre-clinicalActive
Key Facts
About CroiValve
CroíValve is a private, clinical-stage medical device company targeting the significant unmet need in tricuspid regurgitation (TR). The company's core innovation is the DUO™ System, a transcatheter device engineered to coapt with the native valve leaflets, aiming to offer a simpler, more anatomical solution compared to existing repair or replacement approaches. With a seasoned leadership team combining clinical, technical, and commercial expertise, CroíValve is advancing its technology through clinical studies. The company operates in a high-growth potential market but faces competition and the inherent risks of device development and regulatory pathways.
View full company profileTherapeutic Areas
Other Severe Tricuspid Regurgitation Drugs
| Drug | Company | Phase |
|---|---|---|
| TricValve | Relisys Medical Devices | Phase 2/3 |
| Versa Transcatheter Tricuspid Valve Repair System | Versa Vascular | Pre-clinical |
| Trisol Valve | Trisol Medical | Preclinical |
| EVOQUE Tricuspid Valve Replacement System | Edwards Lifesciences | Pivotal |